These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4001847)

  • 21. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
    Lindblad A; Glaumann H; Strandvik B
    Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis.
    Ohkubo H; Okuda K; Iida S; Ohnishi K; Ikawa S; Makino I
    Gastroenterology; 1984 Mar; 86(3):514-20. PubMed ID: 6693014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis.
    Colombo C; Setchell KD; Podda M; Crosignani A; Roda A; Curcio L; Ronchi M; Giunta A
    J Pediatr; 1990 Sep; 117(3):482-9. PubMed ID: 2391610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid concentrations in serum during infancy and childhood.
    Sandberg DH
    Pediatr Res; 1970 May; 4(3):262-7. PubMed ID: 5463656
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum bile acids in alcoholic liver disease. Comparison with histological features of the disease.
    Milstein HJ; Bloomer JR; Klatskin G
    Am J Dig Dis; 1976 Apr; 21(4):281-5. PubMed ID: 1274919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnostic value of fasting individual serum bile acids in anicteric alcoholic liver disease: relation to liver morphology.
    Einarsson K; Angelin B; Björkhem I; Glaumann H
    Hepatology; 1985; 5(1):108-11. PubMed ID: 3967851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Serum concentration of bile acids and portal hypertension in cirrhotic patients. Possible correlations].
    Tarantino G; Cambri S; Ferrara A; Marzano M; Liberti A; Vellone G; Ciccarelli AF
    Riv Eur Sci Med Farmacol; 1989 Jun; 11(3):195-205. PubMed ID: 2640042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postprandial total serum bile acid concentrations in cystic fibrosis.
    Starkey BJ; Goodchild MC
    Monogr Paediatr; 1979; 10():12-8. PubMed ID: 460266
    [No Abstract]   [Full Text] [Related]  

  • 29. Importance of hepatic fibrosis in cystic fibrosis and the predictive value of liver biopsy.
    Lewindon PJ; Shepherd RW; Walsh MJ; Greer RM; Williamson R; Pereira TN; Frawley K; Bell SC; Smith JL; Ramm GA
    Hepatology; 2011 Jan; 53(1):193-201. PubMed ID: 21254170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver function and the diagnostic significance of conjugated cholic acid and chenodeoxycholic acid in serum of African patients with sickle cell disease.
    Bolarin DM
    Acta Trop; 1983 Dec; 40(4):359-64. PubMed ID: 6142634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver disease and common-bile-duct stenosis in cystic fibrosis.
    Gaskin KJ; Waters DL; Howman-Giles R; de Silva M; Earl JW; Martin HC; Kan AE; Brown JM; Dorney SF
    N Engl J Med; 1988 Feb; 318(6):340-6. PubMed ID: 3340104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver dysfunction in cystic fibrosis--beneficial effect of bile acid treatment.
    Riely CA
    Gastroenterology; 1991 May; 100(5 Pt 1):1476-7. PubMed ID: 2013396
    [No Abstract]   [Full Text] [Related]  

  • 33. Endogenous bile acid tolerance test for liver function.
    van Blankenstein M; Frenkel M; van den Berg JW; ten Kate FJ; Bosman-Jacobs EP; Touw-Blommesteyn AC
    Dig Dis Sci; 1983 Feb; 28(2):137-44. PubMed ID: 6825535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual bile acids in portal venous and systemic blood serum of fasting man.
    Ahlberg J; Angelin B; Björkhem I; Einarsson K
    Gastroenterology; 1977 Dec; 73(6):1377-82. PubMed ID: 913977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of serum bile acids in the identification of vinyl chloride hepatotoxicity.
    Liss GM; Greenberg RA; Tamburro CH
    Am J Med; 1985 Jan; 78(1):68-76. PubMed ID: 3966491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum bile acids in Gilbert's syndrome before and after reduced caloric intake.
    Briheim G; Frydén A; Tobiasson P
    Scand J Gastroenterol; 1982 Oct; 17(7):877-80. PubMed ID: 7156881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results with six "kit" radioimmunoassays for primary bile acids in human serum intercompared.
    Roda A; Roda E; Aldini R; Capelli M; Festi D; Sama C; Mazzella G; Morselli AM; Barbara L
    Clin Chem; 1980 Nov; 26(12):1677-82. PubMed ID: 7428151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fasting serum bile acid level in cirrhosis. A semi-quantitative index of hepatic function.
    Islam S; Poupon RE; Barbare JC; Chrétien Y; Darnis F; Poupon R
    J Hepatol; 1985; 1(6):609-17. PubMed ID: 4056358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic significance of fasting serum bile acid in liver disease.
    Hirayama C; Irisa T; Arimura K; Nakamura M
    Acta Hepatogastroenterol (Stuttg); 1976; 23(6):385-91. PubMed ID: 188286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased serum bile acids in cirrhosis with normal transaminases.
    Mannes GA; Stellaard F; Paumgartner G
    Digestion; 1982; 25(4):217-21. PubMed ID: 7166204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.